Difference between revisions of "Category:TRK inhibitors"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "A class of drugs that inhibit tropomyosin receptor kinase (Trk). The first drug in this class is designed to inhibit NTRK fusions. Category: Kinase inhibitors")
 
m
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
A class of drugs that inhibit tropomyosin receptor kinase (Trk). The first drug in this class is designed to inhibit NTRK fusions.
+
A class of drugs that inhibit tropomyosin receptor kinase (Trk). The first targeted drug in this class is designed to inhibit NTRK fusions.
  
[[Category: Kinase inhibitors]]
+
[[Category:Tyrosine kinase inhibitors]]

Latest revision as of 22:26, 22 January 2021

A class of drugs that inhibit tropomyosin receptor kinase (Trk). The first targeted drug in this class is designed to inhibit NTRK fusions.

Pages in category "TRK inhibitors"

The following 4 pages are in this category, out of 4 total.